Replimune (REPL) Invested Capital (2022 - 2026)
Replimune's Invested Capital was $189.76 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 50.5% from $383.51 million a year earlier and down 23.9% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Invested Capital (2022 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Invested Capital at Replimune came in at $249.47 million, down 46.0% from FY2025.
- Invested Capital shows a four-year compound annual growth rate of -11.7% (FY2022 to FY2026).
- In earlier fiscal years, Invested Capital was $462.22 million in FY2025 (+10.2%), $419.32 million in FY2024 (-28.2%), $583.94 million in FY2023 (+42.0%) and $411.23 million in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Invested Capital in data going back to fiscal Q4 2022.
- Compared with a year earlier, Invested Capital has declined for five straight quarters, with an average decline of 30.6% over the last six quarters.
- The best year-over-year quarter for Invested Capital over five years was fiscal Q4 2023 (growth of 42.0%); the worst was fiscal Q3 2026 (a decline of 51.1%).
- Per Business Quant data, REPL's Invested Capital in the three fiscal quarters before Q1 2027 was $249.47 million (Q4 2026), $258.17 million (Q3 2026) and $310.54 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Replimune | 1.09 Bn | 1.09 Bn | - | 189.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189.76 Mn |
| Mar 31, 2026 | 249.47 Mn |
| Dec 31, 2025 | 258.17 Mn |
| Sep 30, 2025 | 310.54 Mn |
| Jun 30, 2025 | 383.51 Mn |
| Mar 31, 2025 | 462.22 Mn |
| Dec 31, 2024 | 528.33 Mn |
| Sep 30, 2024 | 427.03 Mn |
| Jun 30, 2024 | 471.64 Mn |
| Mar 31, 2024 | 419.32 Mn |
| Mar 31, 2023 | 583.94 Mn |
| Mar 31, 2022 | 411.23 Mn |
API Access
Replimune Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();